Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |